- Home
- IMNM vs HIFS Comparison
IMNM vs HIFS Comparison
Compare IMNM & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- HIFS
- Stock Information
- Founded
- IMNM 2006
- HIFS 1834
- Country
- IMNM United States
- HIFS United States
- Employees
- IMNM N/A
- HIFS N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- HIFS Major Banks
- Sector
- IMNM Health Care
- HIFS Finance
- Exchange
- IMNM Nasdaq
- HIFS Nasdaq
- Market Cap
- IMNM 585.5M
- HIFS 518.9M
- IPO Year
- IMNM 2020
- HIFS N/A
- Fundamental
- Price
- IMNM $9.99
- HIFS $241.80
- Analyst Decision
- IMNM Strong Buy
- HIFS
- Analyst Count
- IMNM 5
- HIFS 0
- Target Price
- IMNM $28.60
- HIFS N/A
- AVG Volume (30 Days)
- IMNM 881.8K
- HIFS 12.2K
- Earning Date
- IMNM 11-13-2024
- HIFS 01-17-2025
- Dividend Yield
- IMNM N/A
- HIFS 1.04%
- EPS Growth
- IMNM N/A
- HIFS N/A
- EPS
- IMNM N/A
- HIFS 12.85
- Revenue
- IMNM $10,129,000.00
- HIFS $65,525,000.00
- Revenue This Year
- IMNM N/A
- HIFS N/A
- Revenue Next Year
- IMNM N/A
- HIFS N/A
- P/E Ratio
- IMNM N/A
- HIFS $18.82
- Revenue Growth
- IMNM N/A
- HIFS N/A
- 52 Week Low
- IMNM $8.97
- HIFS $150.11
- 52 Week High
- IMNM $30.96
- HIFS $300.00
- Technical
- Relative Strength Index (RSI)
- IMNM 40.28
- HIFS 40.81
- Support Level
- IMNM $9.24
- HIFS $235.65
- Resistance Level
- IMNM $11.06
- HIFS $245.96
- Average True Range (ATR)
- IMNM 0.74
- HIFS 5.82
- MACD
- IMNM -0.06
- HIFS -0.43
- Stochastic Oscillator
- IMNM 31.78
- HIFS 47.57
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.